What Is a TDDS Manufacturing System?

A Transdermal Drug Delivery System (TDDS) is a medicated adhesive patch that delivers active pharmaceutical ingredients through the skin at a controlled rate. Manufacturing TDDS patches requires precision equipment for:

• Preparing and homogenizing the adhesive drug matrix (hotmelt or solvent-based)
• Coating the matrix onto a release liner at uniform thickness
• Controlled drying to lock in drug concentration and adhesive properties
• Die-cutting or slitting into finished patch dimensions

HUANGHAI's modular TDDS solution supports both hotmelt adhesive and solvent-based formulations, from 100mm pilot runs to commercial-scale production.

Core Manufacturing Modules

1. Adhesive Matrix Mixing System

Why It Matters: Homogeneous API dispersion in the adhesive matrix directly determines patch potency uniformity and shelf-life stability.

Application Scenarios:

• Nicotine, fentanyl, or lidocaine hotmelt adhesive patches
• Hormone patches (estradiol, testosterone) in acrylate matrices
• Solvent-cast matrices for poorly soluble APIs
• R&D feasibility trials at 1–5 kg batch scale

Technical Highlights:

• Jacketed vessel with ±0.5°C temperature control
• High-shear disperser + planetary mixer options
• 316L stainless steel, CIP-compatible
• Inline viscosity monitoring port
• Batch volume: 5–200L (customizable)

2. Precision Coating & Drying Line

Why It Matters: Coating thickness must be uniform to ±2% across the full web width to ensure dose consistency. Drying profiles affect adhesive peel force and drug crystallization.

Core Equipment: MJ150 and MJ150-L precision coating lines.

Application Scenarios:

• Matrix-type patches (adhesive = drug carrier)
• Reservoir-type patches with membrane layer
• Bilayer constructions (backing + matrix)
• Transdermal patches for sustained 24–72h delivery

Technical Specifications:

• MJ150-L — Coating width: 250mm | Speed: 0.2–8 m/min | Drying zones: 3 × independently controlled | Film thickness: 0.05–1.5mm
• MJ150 — Coating width: 130mm | Speed: 0.2–5 m/min | Drying tunnel: 6m | Temp range: up to 120°C
• Doctor blade or slot-die coating head options
• Auto tension control + film shortage alert
• Online thickness scanner (optional)
• Solvent recovery system for Class II/III solvents (optional)

3. Die-Cutting & Slitting

Why It Matters: Final patch geometry must be precise for packaging and patient application. Clean edge cuts prevent adhesive migration.

Application Scenarios:

• Standard oval, round, or rectangular patch shapes
• Custom die-cutting for branded patch designs
• High-speed slitting for roll-to-pouch packaging integration

Technical Highlights:

• Servo-driven registration for ±0.3mm cut accuracy
• Quick-change die tooling
• Compatible with paper/foil/PE backing materials
• Output: up to 200 patches/min (geometry dependent)

4. QC & Validation Support

• Batch manufacturing records (BMR) templates
• IQ/OQ/PQ validation documentation package
• 21 CFR Part 11 compliant data logging (optional)
• Release testing: weight variation, peel adhesion, content uniformity

TDDS vs ODF: Equipment Overlap and Key Differences

HUANGHAI's coating lines (MJ150 / MJ150-L) are designed to handle both ODF (Oral Dissolving Film) and TDDS (Transdermal Patches) with formulation-specific tooling. This dual-use capability is ideal for CDMOs and R&D labs running multiple product types.

Typical TDDS Applications

• Pain Management: Lidocaine, fentanyl, diclofenac patches
• Hormonal Therapy: Estradiol, testosterone, progesterone patches
• Smoking Cessation: Nicotine patches (7mg / 14mg / 21mg)
• CNS / Neurological: Scopolamine (motion sickness), rivastigmine
• Cardiovascular: Nitroglycerine, clonidine patches
• Nutraceutical Patches: Vitamin B12, melatonin, CBD

Ready to Build Your TDDS Line?

Whether you're scaling from lab to pilot or building a commercial CDMO facility, our engineers will help you select the right coating width, drying configuration, and cutting solution for your formulation.